Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effects of α-L-guluronic acid in patients with ankylosing spondylitis
IRCT2016091813739N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of guluronic acid in ankylosing spondylitis (AS), sponsored by Tehran University of Medical Sciences. Started Nov 2016; status: completed.
02
Drugs
guluronic acid
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on IRCT2016091813739N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016091813739N4.